Mark D’Amico
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Molecular Biology top 5%
- Wnt/β-catenin signaling in development and cancer
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
- Kruppel-like factors research
- Ubiquitin and proteasome pathways
- RNA Research and Splicing
Papers in
- Oncology 9
- Cancer-related Molecular Pathways 9
-
- Cancer-related gene regulation 4
- Cell death mechanisms and regulation 3
- RNA modifications and cancer 2
- Epigenetics and DNA Methylation 2
- Co-authors
- Richard G. Pestell (14 shared papers)Chris Albanese (11 shared papers)Avri Ben‐Ze'ev (2 shared papers)Inbal Simcha (1 shared paper)Jacob Zhurinsky (1 shared paper)Michael S. Shtutman (1 shared paper)Maofu Fu (7 shared papers)Richard J. Lee (4 shared papers)
- Journals
- Journal of Biological Chemistry (3 papers)Nature Genetics (1 paper)Molecular Biology of the Cell (1 paper)Cancer Research (1 paper)Molecular Endocrinology (1 paper)
- Partner nations
- United StatesIsraelCanada
In The Last Decade
Mark D’Amico
15 papers receiving 3.4k citations
Mark D’Amico's Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 991
- Molecular Biology 2.6k
- Cancer Research 448
- Cell Biology 350
- Immunology and Allergy 78
Countries citing papers authored by Mark D’Amico
This map shows the geographic impact of Mark D’Amico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D’Amico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D’Amico more than expected).
Fields of papers citing papers by Mark D’Amico
This network shows the impact of papers produced by Mark D’Amico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D’Amico. The network helps show where Mark D’Amico may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D’Amico, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway Hit paper breakdown → | 1999 | 1984 |
| 2 | 2000 | 318 | |
| 3 | 1999 | 260 | |
| 4 | 2003 | 201 | |
| 5 | 1999 | 168 | |
| 6 | 2003 | 134 | |
| 7 | 2003 | 118 | |
| 8 | Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways. | 2002 | 55 |
| 9 | 2000 | 51 | |
| 10 | 1999 | 47 | |
| 11 | 2004 | 34 | |
| 12 | The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis. | 2003 | 26 |
| 13 | 2008 | 20 | |
| 14 | 2007 | 20 | |
| 15 | 2005 | 5 |
About Mark D’Amico
Mark D’Amico is a scholar working on Oncology, Molecular Biology, Cancer Research, Reproductive Medicine and Genetics, having authored 15 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (9 papers), Cancer-related gene regulation (4 papers), Cell death mechanisms and regulation (3 papers), RNA modifications and cancer (2 papers), NF-κB Signaling Pathways (2 papers), Epigenetics and DNA Methylation (2 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Oncology (991 citations), Molecular Biology (2.6k citations), Cancer Research (448 citations), Cell Biology (350 citations) and Immunology and Allergy (78 citations). Mark D’Amico has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Richard G. Pestell, Chris Albanese, Avri Ben‐Ze'ev, Inbal Simcha, Jacob Zhurinsky, Michael S. Shtutman, Maofu Fu, Richard J. Lee, Genichi Watanabe and Kongming Wu. Their work appears in journals such as Journal of Biological Chemistry, Nature Genetics, Molecular Biology of the Cell, Cancer Research and Molecular Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.